Quanterix (QTRX) Competitors $5.85 +0.34 (+6.17%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$5.83 -0.02 (-0.34%) As of 07/25/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock QTRX vs. SIBN, TRNS, EYPT, ALNT, LAB, CTKB, AEHR, SENS, QSI, and MASSShould you be buying Quanterix stock or one of its competitors? The main competitors of Quanterix include SiBone (SIBN), Transcat (TRNS), Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Aehr Test Systems (AEHR), Senseonics (SENS), Quantum-Si (QSI), and 908 Devices (MASS). Quanterix vs. Its Competitors SiBone Transcat Eyepoint Pharmaceuticals Allient Standard BioTools Cytek Biosciences Aehr Test Systems Senseonics Quantum-Si 908 Devices SiBone (NASDAQ:SIBN) and Quanterix (NASDAQ:QTRX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment and earnings. Do institutionals and insiders hold more shares of SIBN or QTRX? 98.1% of SiBone shares are held by institutional investors. Comparatively, 86.5% of Quanterix shares are held by institutional investors. 4.0% of SiBone shares are held by insiders. Comparatively, 6.9% of Quanterix shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts rate SIBN or QTRX? SiBone presently has a consensus target price of $22.50, suggesting a potential upside of 30.43%. Quanterix has a consensus target price of $13.50, suggesting a potential upside of 130.77%. Given Quanterix's higher possible upside, analysts plainly believe Quanterix is more favorable than SiBone.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SiBone 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Quanterix 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40 Is SIBN or QTRX more profitable? SiBone has a net margin of -15.03% compared to Quanterix's net margin of -36.82%. Quanterix's return on equity of -15.07% beat SiBone's return on equity.Company Net Margins Return on Equity Return on Assets SiBone-15.03% -16.00% -11.69% Quanterix -36.82%-15.07%-12.26% Which has more risk and volatility, SIBN or QTRX? SiBone has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. Comparatively, Quanterix has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500. Does the media refer more to SIBN or QTRX? In the previous week, Quanterix had 3 more articles in the media than SiBone. MarketBeat recorded 6 mentions for Quanterix and 3 mentions for SiBone. SiBone's average media sentiment score of 1.70 beat Quanterix's score of 1.32 indicating that SiBone is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SiBone 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Quanterix 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings and valuation, SIBN or QTRX? SiBone has higher revenue and earnings than Quanterix. SiBone is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSiBone$167.18M4.40-$30.91M-$0.64-26.95Quanterix$137.42M2.13-$38.53M-$1.30-4.50 SummarySiBone beats Quanterix on 10 of the 16 factors compared between the two stocks. Get Quanterix News Delivered to You Automatically Sign up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QTRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QTRX vs. The Competition Export to ExcelMetricQuanterixMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$292.23M$10.63B$5.75B$9.55BDividend YieldN/A2.02%4.71%4.01%P/E Ratio-4.5017.3728.4120.06Price / Sales2.1328.78460.5299.93Price / CashN/A23.4336.1858.54Price / Book0.683.698.655.87Net Income-$38.53M$234.77M$3.25B$258.89M7 Day Performance8.94%6.32%4.30%3.70%1 Month Performance-10.96%7.94%10.58%11.71%1 Year Performance-62.40%-13.57%35.69%17.98% Quanterix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QTRXQuanterix2.6421 of 5 stars$5.85+6.2%$13.50+130.8%-61.7%$292.23M$137.42M-4.50460Positive NewsSIBNSiBone4.0766 of 5 stars$17.32+0.7%$22.50+29.9%+8.0%$738.18M$167.18M-27.06350News CoverageTRNSTranscat2.9711 of 5 stars$86.45-0.2%$112.20+29.8%-38.6%$805.71M$278.42M55.421,245EYPTEyepoint Pharmaceuticals1.4909 of 5 stars$10.17-1.8%$25.67+152.4%+10.8%$699.81M$56.04M-4.22120ALNTAllient2.5967 of 5 stars$39.11+1.3%$31.00-20.7%+42.2%$662.09M$516.06M66.292,525News CoverageLABStandard BioTools3.6061 of 5 stars$1.25-5.3%$2.50+100.0%-40.2%$474.78M$169.69M-3.57620News CoverageUpcoming EarningsCTKBCytek Biosciences3.1915 of 5 stars$3.35-2.9%$5.60+67.2%-43.2%$424.31M$197.05M-37.22500News CoveragePositive NewsAEHRAehr Test Systems1.8505 of 5 stars$13.86-1.8%$25.00+80.4%+23.1%$412.61M$58.97M-106.6190News CoverageInsider TradeSENSSenseonics2.0981 of 5 stars$0.49-0.8%$1.70+244.9%+20.1%$322.46M$23.68M-3.7990Positive NewsQSIQuantum-Si2.1921 of 5 stars$1.73flat$3.48+100.9%+67.8%$317.45M$3.44M-2.54150News CoverageMASS908 Devices1.304 of 5 stars$6.72-3.2%$5.33-20.6%+33.7%$240.98M$59.63M-12.4460News Coverage Related Companies and Tools Related Companies SIBN Alternatives TRNS Alternatives EYPT Alternatives ALNT Alternatives LAB Alternatives CTKB Alternatives AEHR Alternatives SENS Alternatives QSI Alternatives MASS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QTRX) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Goldco Precious Metals | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quanterix Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Quanterix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.